Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Esophageal Squamous Cell Carcinoma 5 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Rectal Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Testicular Neoplasms 1 Surgery 1 Stress, Psychological 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solitary Fibrous Tumor, Pleural 1 Seminoma 1 Recurrence 1 Postoperative Complications 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Neoadjuvant Therapy × 1 year × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡